Project Details
Description
A Phase 1/2 Randomized Parallel Arm, Intra-patient Dose Titration Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of CNSA-001 (Sepiapterin) in Adult and Adolescent Primary Tetrahydrobiopterin Deficient Patients with Hyperphenylala
| Status | Finished |
|---|---|
| Effective start/end date | 6/25/18 → 12/31/20 |
Funding
- CENSA PHARMACEUTICALS INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.